Century Therapeutics, Inc. ( IPSC) - Key Metrics
IPSC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.17 | -$0.10 | -$0.10 |
| 2026Q1 | $0 | -$0.25 | -$0.29 | -$0.30 |
| 2025Q4 | $0 | -$0.22 | -$0.19 | -$0.19 |
| 2025Q3 | $0 | -$0.40 | -$0.30 | -$0.30 |
| 2025Q2 | $0 | -$0.38 | -$0.32 | -$0.32 |
IPSC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.60 |
| 2026Q1 | 0% | -2.26 |
| 2025Q4 | 0% | -1.13 |
| 2025Q3 | 0% | -0.31 |
| 2025Q2 | 0% | -0.37 |
IPSC
Price: $1.37
52 week price:
Earnings Per Share: -1.00 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 69234
Market Capitalization: 271.6 million